AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks
Published
Read more on https://www.fxstreet.com
Full ArticlePublished
Read more on https://www.fxstreet.com
Full ArticleModerna Inc (NASDAQ:MRNA) has confirmed its COVID-19 vaccine achieved a 94% success in its recent phase III trial and that it will..
12:30 pm: A third promising vaccine has emerged After a strong open, US markets gave back some gains. At midday, the Dow improved..